Skip to Content

Join the 'Onxol' group to help and get support from people like you.

Onxol News

Cooling Mitts, Socks May Ease a Major Chemo Side Effect

Posted 18 Oct 2017 by Drugs.com

WEDNESDAY, Oct. 18, 2017 – Many cancer drugs can cause debilitating nerve damage as a side effect. But a small study suggests that simple cold wraps to the hands and feet might prevent it. The side effect, known as peripheral neuropathy, damages nerves in the limbs. This often leads to pain, numbness and tingling, and difficulty with balance and using the hands and fingers. There are treatments ...

Treatment Costs Can Be Another Blow to Cancer Patients

Posted 27 Jul 2017 by Drugs.com

THURSDAY, July 27, 2017 – The emotional and physical costs of cancer can be staggering. But the financial side of cancer is also a great burden, with many patients in the United States struggling to pay for treatment, new research reveals. "The current health law has greatly improved access to meaningful health coverage for cancer patients, survivors and all those with chronic diseases," Chris ...

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 19 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In ...

Publicly Funded Cancer Trials Gained Americans 3 Million More Years

Posted 6 Jun 2017 by Drugs.com

TUESDAY, June 6, 2017 – Public-funded trials have significantly extended the lives of people diagnosed with cancer, according to new research. SWOG, the clinical trials network funded by the U.S. National Cancer Institute (NCI), has involved more than 200,000 patient volunteers. These trials have led to approval of 14 new cancer drugs and more than 100 changes to cancer care standards. All told, ...

Half Report Severe Side Effects From Breast Cancer Therapy

Posted 24 Jan 2017 by Drugs.com

TUESDAY, Jan. 24, 2017 – About half of early stage breast cancer patients experience severe side effects from their treatment, a new study finds. "It's in patients' best interest to receive their treatments on time and on schedule, whenever possible, to give them the best possible outcome," said study author Dr. Steven Katz. He's professor of health management and policy at the University of ...

U.S. Pays Highest Prices for Cancer Meds: Study

Posted 6 Jun 2016 by Drugs.com

MONDAY, June 6, 2016 – The United States pays the highest prices in the world for generic and brand-name cancer drugs, a new study has found. However, as the world's wealthiest nation, the United States is better able to pay for those pricey drugs than poorer countries with somewhat lower medication prices, added study lead author Dr. Daniel Goldstein. People in China and India are much less ...

Less Chemo for Obese Ovarian Cancer Patients Linked to Worse Survival Rates

Posted 6 Jul 2015 by Drugs.com

MONDAY, July 6, 2015 – Ovarian cancer patients who are overweight or obese are often given lower doses of chemotherapy per pound of body weight, but this may reduce the odds of survival, a new study suggests. "There is a lot of uncertainty in what proper chemotherapy dosing levels should be for overweight and obese patients, based on concerns that using the full dose based on weight or body size ...

Drug-Coated Balloon Catheter Approved

Posted 13 Oct 2014 by Drugs.com

MONDAY, Oct. 13, 2014 – The first drug-coated balloon catheter designed to clear narrowed or blocked arteries in the thigh and knee has been approved by the U.S. Food and Drug Administration. The Lutonix 035 Drug Coated Balloon Percutaneous Transluminal Angioplasty Catheter has a balloon coated with the drug paclitaxel, which may help prevent re-narrowing of the affected artery after the ...

Medicines Are Biggest Culprit in Fatal Allergic Reactions: Study

Posted 10 Oct 2014 by Drugs.com

THURSDAY, Oct. 9, 2014 – Although food allergies have garnered a lot of attention lately, a new study reports that medications are actually the biggest cause of sudden deaths related to allergy. Over a little more than a decade, nearly 60 percent of the allergy-related deaths were caused by medications, while less than 7 percent were caused by food allergies, the study found. "Medications can be ...

Fine-Tuning Breast Cancer Treatments: What Works Better?

Posted 3 Jun 2013 by Drugs.com

MONDAY, June 3 – Two common schedules used for the chemotherapy paclitaxel (Taxol) are equally effective at controlling breast cancer, but fewer side effects are found with the weekly regimen rather than every two weeks, according to a new study. The estimated five-year progression-free survival rates were the same for both groups, said Dr. G. Thomas Budd, who led the study. While 82 percent of ...

Cancer Chemotherapy Tied to Slight Rise in Risk for Leukemia

Posted 14 Feb 2013 by Drugs.com

THURSDAY, Feb. 14 – Chemotherapy can be a lifesaver for thousands of cancer patients, but a new study suggests that it might slightly raise the odds for a type of leukemia later in life. Over the past 30 years, the risk for acute myeloid leukemia (AML) has increased for patients who underwent chemotherapy for certain forms of cancer, particularly non-Hodgkin lymphoma, the new study found. On the ...

FDA Medwatch Alert: Hospira Injectable Drug Products: Recall - Visible Particulates from Defective Glass Vials

Posted 18 Jul 2012 by Drugs.com

Including certain lots of the following products: carboplatin cytarabine paclitaxel methotrexate [Posted 07/16/2012] ISSUE: Hospira and FDA notified healthcare professional of a nationwide recall of certain injectable drug products, due to visible particles embedded in the glass located at the neck of the vial. There may be potential for product to come into contact with the embedded particles ...

'Uncertainty' Remains Over Supply of Key Cancer Drugs

Posted 4 Jun 2012 by Drugs.com

MONDAY, June 4 – John Mahan, a 58-year-old Nashville firefighter battling a gastrointestinal cancer, couldn't believe what he was hearing last July. His doctor had just told him that his clinic had run out of injectable fluorouracil (5-FU), the generic chemotherapy Mahan needed to keep his tumor at bay. "My initial reaction was, 'you've got to be kidding, right?'" he said. Unfortunately, the ...

New 'Personalized' Drugs Show Promise Against Melanoma, Lung Cancer

Posted 4 Jun 2012 by Drugs.com

MONDAY, June 4 – There's more encouraging news from the brave new world of "personalized" cancer care, with three drugs showing promise against some of the most common cancers. Two studies to be presented Monday at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago focus on drugs that treated advanced melanoma, while a third study looks at a gene-targeted chemotherapy for ...

Older Drug for Advanced Breast Cancer Beat Newer, Pricier Meds

Posted 4 Jun 2012 by Drugs.com

MONDAY, June 4 – Even in the field of cancer treatment, sometimes newer isn't necessarily better. That may be the case for patients with advanced breast cancer, who appeared to fare better in a new study when they took an older drug, Taxol (paclitaxel), instead of two newer and more expensive rivals. Both of those newer medications, Abraxane and Ixempra, failed to outperform Taxol in terms of ...

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Kaposi's Sarcoma, Non-Small Cell Lung Cancer, Ovarian Cancer, Wilms' Tumor

Onxol Patient Information at Drugs.com